KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：[email protected]
| Catalog Number | YR1127 |
|---|---|
| Product Name | Anti-Human MSTN Recombinant Antibody(Stamulumab) |
| Molecular Name | Stamulumab |
| Alias | Anti-MSTN Recombinant Antibody, Research Grade Stamulumab |
| CAS Number | 705287-60-1 |
| Target | MSTN[Homo sapiens] |
| Isotype | IgG1 |
| Clonity | Monoclonal |
| Host | Mouse |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | FuncS, IF, Neut, ELISA, FCM, IP, ICC |
| Buffer | PBS, pH7.5 |
| Background | Stamulumab (MYO-029) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD). Stamulumab was formulated and tested by Wyeth in Collegeville, Pennsylvania. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：[email protected]
Hot Line： +1-315-239-3085
Technical Support：[email protected]
